Epidemiologie - France Portal | Health Databases

Home

Catalogue

Catalogue
ARCHIVES

Covid-19

Resources

Lexicon
Legal notices

Useful links

General links
Covid-19 links

Login in to your account

Email address Password

You do not have an account yet ? Sign up !

You have forgotten your password ?

Portail Epidémiologique

ITMO public health Aviesan

Aviesan

Archives

Search with one or more keywords

All records French records only English records only

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml

Export to XML

Please choose the format :

pdf

Export to PDF

Which version do you want to export ?

Download full content

Download light content

csv

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

ARCHIVES : 309 forms

Sorting of results :

FOCUS - Cohort of Patients with Hypertrophic Cardiomyopathy: Prospective Screening for Fabry Disease

Head : Hagège Albert, Inserm U633 Cardiology Department at Georges Pompidou European Hospital [Hôpital Européen Georges-Pompidou]

Version 1

55

Last update : 07/01/2018

ARCHIVE

FOCUS - Cohort of Patients with Hypertrophic Cardiomyopathy: Prospective Screening for Fabry Disease

Head : Hagège Albert, Inserm U633 Cardiology Department at Georges Pompidou European Hospital [Hôpital Européen Georges-Pompidou]

Main objective

To estimate the prevalence of Fabry disease in a population of men and women with hypertrophic cardiomyopathy (HCM) consistent with primary cardiomyopathy.

Inclusion criteria

– men and women
– between 18 and 79 years old
– with hypertrophic cardiomyopathy

Last update : 07/01/2018

POLA - Longitudinal Study on Age-Related Eye Diseases

Head : Delcourt Cécile, Centre de Recherche Inserm U897 "Epidémiologie et Biostatistiques"

Version 3

56

Last update : 09/05/2017

ARCHIVE

POLA - Longitudinal Study on Age-Related Eye Diseases

Head : Delcourt Cécile, Centre de Recherche Inserm U897 "Epidémiologie et Biostatistiques"

Main objective

To investigate risk factors of age-related eye diseases (Age-Related Macular Degeneration (AMD), cataracts)

Inclusion criteria

Elderly people over 60 years of age living in Sète (Hérault)

Last update : 09/05/2017

CASC - Behaviors and attitudes of cyclists concerning road safety and use of helmet

Head : LAGARDE Emmanuel, U897 PRÉVENTION ET PRISE EN CHARGE DES TRAUMATISMES ( Equipe de l'ISPED - Institut de Santé Publique, d'Epidémiologie et de Développement)

Version 2

57

Last update : 08/01/2020

ARCHIVE

CASC - Behaviors and attitudes of cyclists concerning road safety and use of helmet

Head : LAGARDE Emmanuel, U897 PRÉVENTION ET PRISE EN CHARGE DES TRAUMATISMES ( Equipe de l'ISPED - Institut de Santé Publique, d'Epidémiologie et de Développement)

Main objective

Understand the relation between the use of the helmet and risk behaviors in urban cyclists. Enlighten the decision concerning road safety politics.

Inclusion criteria

People borrowing a bicycle in a municipal structure for a minimum period of 4 months

Last update : 08/01/2020

- Baromètre santé médecins généralistes

Head : Gautier Arnaud

Version 1

58

Last update : 01/01/2019

ARCHIVE

- Baromètre santé médecins généralistes

Head : Gautier Arnaud

Main objective

Know the opinions, behaviors and practices of general practitioners in terms of prevention; various themes are addressed here, in particular opinions with regards to vaccination, cancer screening and viral hepatitis, treatment for addiction problems, etc.
It also aims to identify preventive practices (primary, secondary), detect the difficulties encountered… especially in order to guide, strengthen preventive actions with health professionals.

Inclusion criteria

General practitioner exercising in metropolitan France through liberal activity and included in the CEGEDIM file.

Last update : 01/01/2019

PREVAS - Etude de PREValence de l’Asthme persistant Sévère mal contrôlé

Head : Anne Ponthieux, Direction Relations Economiques et Institutionnelles

Version 1

59

Last update : 09/05/2017

ARCHIVE

PREVAS - Etude de PREValence de l’Asthme persistant Sévère mal contrôlé

Head : Anne Ponthieux, Direction Relations Economiques et Institutionnelles

Main objective

Assessment of prevalence of uncontrolled severe persistent asthma in a representative population of asthmatic patients followed by pneumologist or allergy specialist

Inclusion criteria

severe persistent asthmatic patients viewed in routine consultation, with controledl or uncontrolled asthma in the previous year.

Last update : 09/05/2017

PROXAIR - Etude de PROXimologie dans l’Asthme persIstant sévèRe

Head : Ponthieux Anne, Direction Relations Économiques et Institutionnelles

Version 1

60

Last update : 09/05/2017

ARCHIVE

PROXAIR - Etude de PROXimologie dans l’Asthme persIstant sévèRe

Head : Ponthieux Anne, Direction Relations Économiques et Institutionnelles

Main objective

Assess physical, psychic and socio-economic impact on patients and spouse of severe persistent asthma treated with high-dose inhaler steroids and long-acting ß2 agonists (LABA), according to the asthma control level

Inclusion criteria

Patient inclusion Criteria :
- Ambulatory patients, able to cooperate, of either sex, at least 18 years of age.
- Patients with severe persistent asthma receiving for at least three months a continuous and stable treatment of high-dose inhaler steroids (≥ 1 000 µg/d of beclometasone dipropionate excluding micronized forms in metered-dose inhalers, ≥ 800 µg/d of beclometasone dipropionate in micronized form in metered-dose inhalers or ≥ 800 µg/j of budesonide or ≥ 500 µg/d of fluticasone propionate) and of inhaled long-acting ß2 agonists, administered:
either in the form of two specialties using one or two of the following inhalers: Aerolizer®, standard metered-dose inhaler, Autohaler, Diskus®, Turbuhaler®,
or in the form of a fixed association using one of the following inhalers: standard metered-dose inhaler, Diskus®, Turbuhaler®.
- Patients with FEV measurement in the previous month.
- Patients who brought their inhaled steroid treatment and inhaled long-acting ß2-agonist at the time of consultation.
- Patients in couple whether or not married
- Patients and relatives agree to participate

Patient non-inclusion Criteria :
- Patients with a non-asthmatic OCPD.
- Patients who had inhaled steroids or lLABA treatment change in the previous three months (add-on or change of drug, posology change).
- Patients and relatives refusing to participate to the study
- Parents/ those close unable to complete a self-questionnaire.
- Patients who do not live as a couple

Last update : 09/05/2017

Previous
1
...
4
5
6
7
8
9
10
11
12
13
14
15
16
...
52
Next

Please wait...

ABOUT

Help about your workspace

CATALOG

RESOURCES

USEFUL LINKS

This site complies with the HONcode standard for trustworthy health information:
verify here.

8 rue de la Croix Jarry

75013 Paris

Phone : +33 1 44 23 67 47

portail-epidemiologie@inserm.fr

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

XXX

View Edit Create here